FDA Clears DyAnsys Neurostimulation Device Primary Relief to Treat Post-Cardiac Surgery Pain

PALO ALTO, Calif., Sept. 22, 2022 /PRNewswire/ -- DyAnsys, Inc., has announced that Primary Relief, a percutaneous electrical neurostimulation device, has been approved to treat pain following a cardiac surgery. Primary Relief offers safe and viable post-operative pain relief that reduces...

Click to view original post